Data from Australia and New Zealand shows that patient survival rates in those countries were significantly higher among home hemodialysis patients compared to peritoneal dialysis patients.
The Incident Cohort Study, the first of its size, was completed by the Australian and New Zealand Dialysis and Transplant Registry and showed that the five-year survival rate for home hemodialysis is at 85% while the survival rate for peritoneal dialysis patients was 44%.
The data was presented in the article, “An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry);’ by Nadeau-Fredette et al. and published in the June issue of the Clinical Journal of the American Society of Nephrology.
The survival advantage of home hemodialysis over peritoneal dialysis was evident in multiple frames, including younger and older patients, non-diabetics and diabetics, and early and late follow-up.
The Incident Cohort Study was the largest of its kind and assessed all Australian and New Zealand adult patients receiving home dialysis on day 90 after initiation of renal replacement therapy between 2000 and 2012. It included 10,710 patients on incident peritoneal dialysis and 706 patients on incident home hemodialysis and found that the risk of death-censored technique failure for home hemodialysis was 66% lower than peritoneal dialysis.
Currently, less than 2% of dialysis patients in the U.S. are performing home hemodialysis, versus approximately 9% performing peritoneal dialysis.